During the past decade, University of Minnesota Health Clinics and Surgery Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Minnesota Health Clinics and Surgery Center" #1 sponsor was "ERYtech Pharma" with 1 trials, followed by "Incyte Corporation" with 1 trials sponsored, "Mirati Therapeutics Inc." with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "NovoCure GmbH" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Minnesota Health Clinics and Surgery Center" #1 collaborator was "Autoimmunity Centers of Excellence" with 1 trials as a collaborator, "DARPA (United States Department of Defense)" with 1 trials as a collaborator, "Rho Federal Systems Division, Inc." with 1 trials as a collaborator and "University of Minnesota" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University of Minnesota Health Clinics and Surgery Center" are "Adult-type Diffuse Gliomas" (1 trials), "Advanced Solid Tumors" (1 trials), "Advanced or Metastatic Solid Malignancies" (1 trials), "Glioblastoma" (1 trials) and "Glioblastoma Multiforme" (1 trials). Many other conditions were trialed in "University of Minnesota Health Clinics and Surgery Center" in a lesser frequency.

Most popular intervention types in "University of Minnesota Health Clinics and Surgery Center" are "Drug" (5 trials), "Device" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CMRI" (1 trials), "Enfortumab Vedotin-Ejfv" (1 trials), "Gemcitabine plus Abraxane" (1 trials), "Ipilimumab" (1 trials) and "Irinotecan plus 5-FU plus leucovorin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Minnesota Health Clinics and Surgery Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "University of Minnesota Health Clinics and Surgery Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in University of Minnesota Health Clinics and Surgery Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Minnesota Health Clinics and Surgery Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".